License U of T Technologies

Who is this for?

Industry and other parties interested in licensing or otherwise using University of Toronto (U of T) technologies or working with spinoff companies based on U of T intellectual property.

What do I need before I can begin?

No information is required to begin. If you have questions regarding licensing University of Toronto (U of T) technologies or working with our spinoff companies, please reach out to the Innovations & Partnerships Office: Director, Innovations at 416-946-5515.

Technology Licensing & Startup Opportunities

The University of Toronto (U of T) is a global leader in turning research into products, services, companies and jobs. The Innovations & Partnerships Office (IPO) is your one-stop-shop to license these technologies or work with spinoff companies based on U of T intellectual property (IP). IPO’s team of technology transfer professionals make the process as quick and easy as possible.

Use the Technology Explorer below to discover market-ready innovations and companies based on U of T IP or contact us to find custom solutions.

Deep Tech Download Newsletter

In the last 5 years, companies emerging from U of T Research have secured more than $1.5 billion in investment and capital. We're #1 in Canada for research-based startups and our ecosystem is among the top 10 university-managed incubators in the world.

Sign up for Deep Tech Download, our quarterly newsletter that features active investment opportunities and the latest on these research-based companies.

Technology Explorer

Technology Keywords
Nasal Delivery of Highly Effective COVID-19 Vaccines using Helper-Dependent Adenoviral Vectors Virus , Covid-19 , SARS-COV-2 , vaccine , mRNA , adenovirus 
The Glucose Meter as a Detection System for Point-of-Care Gene Circuit Diagnostics Point-of-Care , Covid-19 , Diagnostics , Molecular Detection , Synthetic Biology , SARS-COV-2 , Cell Free , Protein Syntheis , Glucose Meter , PCR , Typhoid , Covid-19 , Reporter Gene , Virus , Bacteria , Ag Tech , Agriculture , Food Safety , Animal Health 
The Glucose Meter as a Detection System for Point-of-Care Gene Circuit Diagnostics Point-of-Care , Covid-19 , Diagnostics , Molecular Detection , Synthetic Biology , SARS-COV-2 , Cell Free , Protein Syntheis , Glucose Meter , PCR , Typhoid , Covid-19 , Reporter Gene , Virus , Bacteria , Ag Tech , Agriculture , Food Safety , Animal Health 
Assay for Rapid and Sensitive Detection of SARS-CoV-2 Antibodies Covid-19 , SARS-COV-2 , Immunoassay , Diagnostics , Clinical Tests , Virus 
Integrated Quantum Dot Barcode Smartphone Optical Device for Diagnosis of COVID-19 Covid-19 , Point-of-Care , Nanomaterials and Nanoparticles , Quantum Dots , Portable Diagnostics , Patient Care , Semiconductors , Medical Devices , Cartridge 
Immunotyping COVID-19 Patients Using Novel Protein Complementation-Based Assay Covid-19 , Diagnostics , Protein-Protein Interactions , Infectious Diseases , Clinical Tests , Pandemic , Immunoassay , SARS-COV-2 , Virus , Antibodies 
Rapid, remote vital sign monitoring and screening Advanced Health Technologies , Covid-19 , Remote monitoring , Patient Care , Biometrics , Biomedical engineering , Biomedical Imaging , Biosensor , Software , 3D imaging , Image and video processing , Screening 
Automatic Learning Filters to Improve the Accuracy of Sensing Algorithms Artificial Intelligence (AI) , Machine Learning , Data Analytics , Neural Networks , Wearable Tech , Software , Covid-19 , Remote monitoring 
Responsive Antiviral Biomaterials Biomaterials , Companies , Dentistry , Drug Delivery , Medical Implants and Prosthetics , Nanomaterials and Nanoparticles , Covid-19 

VPRI Role

  • Market U of T technologies to industry
  • Support the development of startup companies
  • Negotiate license agreements with interested companies
  • Assist in finding partners and funding to support proof-of-concept and commercialization
  • Support long-term relationships with strategic partners that help develop early-stage discoveries into market-ready technologies and products

VPRI Contact

Staff

Jennifer Fraser

Director, Innovations
Innovations & Partnerships Office (IPO)
(416) 946-5515